FGFR2 Gene Rearrangement
2 clinical trials · Condition
◉ Watch FGFR2 Gene Rearrangement
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced Intrahepatic Cholangiocarcinoma Patients With FGFR-2 Fusion or Rearrangement (NCT06728410) | Mehmet Akce | 2026-01-27 |
| Pemigatinib After Curative Local Therapy in Advanced iCCA With FGFR2 Fusion/Rearrangements (NCT05565794) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2022-11-11 |
Track FGFR2 Gene Rearrangement automatically
Every clearance here is in the API, with alerts when new ones post.